The outpatient medical portfolio is expected to gain from favorable outpatient visit trends. Ventas’ accretive investments to expand its research portfolio are encouraging. Zacks Investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback